Wegovy’s High-Dose Upgrade: Breakthrough or Risky Leap?
The FDA has just approved a much higher dose of Wegovy the popular weight-loss drug that’s already…
Compass vs Zillow: The Battle Over Home Listings Ends, But the Debate Continues
Here’s the deal — Compass has officially dropped its lawsuit against Zillow. After months of legal back-and-forth,…
Morgan Stanley’s Mike Wilson Warns a “Stealth Correction” Is Already Hitting the Stock Market
In a recent CNBC interview, Morgan Stanley strategist Mike Wilson summed up the current stock market situation…
Claude AI Faces Glitches While Topping Apple’s App Store
Anthropic’s AI chatbot Claude had a bit of a rough moment on Monday. Even while sitting comfortably…
Diageo’s Warning Sends Kentucky Bourbon Shares Lower
Wall Street had a tough morning — especially if you’re in the bourbon business. Shares of several…
A Big Shift for Personalized Genetic Medicine
The FDA is finally putting real structure behind something that, not long ago, sounded futuristic — fully…
Meta Bets Big on Nvidia’s Next-Gen AI Chips in Expanded Partnership
Here’s the deal. Nvidia and Meta aren’t just continuing their relationship — they’re expanding it in a…
The Legal Battle Over Social Media and Teen Mental Health
Here’s the thing. The spotlight is now firmly on Meta CEO Mark Zuckerberg as he prepares to…
Paramount Skydance says it’s ready to talk — but the price question still hangs
Let’s be honest. This feels less like a peace offering and more like a cautious truce.Paramount Skydance…
